JPS6210508B2 - - Google Patents

Info

Publication number
JPS6210508B2
JPS6210508B2 JP55177066A JP17706680A JPS6210508B2 JP S6210508 B2 JPS6210508 B2 JP S6210508B2 JP 55177066 A JP55177066 A JP 55177066A JP 17706680 A JP17706680 A JP 17706680A JP S6210508 B2 JPS6210508 B2 JP S6210508B2
Authority
JP
Japan
Prior art keywords
acid
methyl
general formula
oxo
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55177066A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5692871A (en
Inventor
Kooren Shunuaa Rodonii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS5692871A publication Critical patent/JPS5692871A/ja
Publication of JPS6210508B2 publication Critical patent/JPS6210508B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
JP17706680A 1979-12-18 1980-12-15 Isoquinolineacetic acid Granted JPS5692871A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/104,939 US4283539A (en) 1979-12-18 1979-12-18 Isoquinoline acetic acids

Publications (2)

Publication Number Publication Date
JPS5692871A JPS5692871A (en) 1981-07-27
JPS6210508B2 true JPS6210508B2 (en, 2012) 1987-03-06

Family

ID=22303241

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17706680A Granted JPS5692871A (en) 1979-12-18 1980-12-15 Isoquinolineacetic acid

Country Status (7)

Country Link
US (1) US4283539A (en, 2012)
EP (1) EP0030861B1 (en, 2012)
JP (1) JPS5692871A (en, 2012)
DE (1) DE3064453D1 (en, 2012)
DK (1) DK149569C (en, 2012)
GR (1) GR72804B (en, 2012)
IE (1) IE50524B1 (en, 2012)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
EP0796168B1 (de) * 1994-12-06 1998-05-20 SIG Schweizerische Industrie-Gesellschaft Quersiegelvorrichtung für eine schlauchbeutel-verpackungsmaschine
GB9424842D0 (en) * 1994-12-09 1995-02-08 British Tech Group Pharmaceutical compositions
ATE404539T1 (de) 1997-10-02 2008-08-15 Eisai R&D Man Co Ltd Kondensierte pyridinderivate
JP3494990B2 (ja) 1998-03-31 2004-02-09 ザ インスティテューツ フォア ファーマスーティカル ディスカヴァリー エルエルシー 置換されたインドールアルカノール酸
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
WO2002090334A1 (en) 2001-05-08 2002-11-14 Kudos Pharmaceuticals Limited Isoquinolinone derivatives as parp inhibitors
AU2003229953A1 (en) 2002-04-30 2003-11-17 Kudos Pharmaceuticals Limited Phthalazinone derivatives
CN1684685A (zh) * 2002-07-26 2005-10-19 药物研发有限责任公司 取代的吲哚基链烷酸衍生物和含有其的治疗糖尿病并发症用配制剂
WO2004054979A1 (ja) * 2002-12-18 2004-07-01 Takeda Pharmaceutical Company Limited Ｊｎｋ阻害剤
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
CN101809017A (zh) 2007-09-14 2010-08-18 阿斯利康(瑞典)有限公司 酞嗪酮衍生物
CA2702429A1 (en) 2007-10-17 2009-04-23 Kudos Pharmaceuticals Limited Crystalline form l 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
BR122021018683B1 (pt) 2008-10-07 2022-11-16 Kudos Pharmaceuticals Limited Formulação farmacêutica de 4-[3-(4-ciclopropanocarbonil- piperazina-1-carbonil)-4-flúor- benzil]-2h-ftalazin-1-ona, uso de um polímero de matriz, forma de dosagem e método para produzir uma dispersão amorfa sólida
TW201212916A (en) * 2010-06-23 2012-04-01 Taisho Pharmaceutical Co Ltd Isoquinoline derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4036964A (en) * 1973-10-11 1977-07-19 Beecham Group Limited Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis

Also Published As

Publication number Publication date
DK536480A (da) 1981-06-19
IE802661L (en) 1981-06-18
JPS5692871A (en) 1981-07-27
EP0030861B1 (en) 1983-07-27
DK149569B (da) 1986-07-28
GR72804B (en, 2012) 1983-12-05
EP0030861A3 (en) 1981-09-23
EP0030861A2 (en) 1981-06-24
US4283539A (en) 1981-08-11
DK149569C (da) 1987-02-02
DE3064453D1 (en) 1983-09-01
IE50524B1 (en) 1986-04-30

Similar Documents

Publication Publication Date Title
JPS6210508B2 (en, 2012)
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
US4855298A (en) 6-Halo-1,2,3,4-tetrahydroquinazoline-4-spiro-4-imidazolidine-2,2'5'-triones useful for the treatment and prophylaxis of diabetic complications
US4200642A (en) Spiro-oxazolidindiones
JPS6035350B2 (ja) 右旋性スピローヒダントイン
JPH10511084A (ja) ポリアリールカルバモイルアザ及びカルバモイルアルカン二酸
JPH0629270B2 (ja) Ｎ―置換２―アミノチアゾール類及び治療用組成物
HU206714B (en) Process for producing pyridazine derivatives
JPS6222986B2 (en, 2012)
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
US4985453A (en) Parabanic acid derivatives and pharmaceutical compositions thereof
JPS6033433B2 (ja) ハロゲン置換ベンゾピラン−４−カルボン酸およびその誘導体
JPH04247082A (ja) 新スピロ〔４．５〕デカン化合物および医薬品組成物
US4226875A (en) Novel spiro-oxazolidinediones
IE61901B1 (en) "Substituted 1h-imidazoles"
JPS63295566A (ja) キノキサリノン誘導体
JPS62252774A (ja) フタラジン誘導体およびその製造法
US4209527A (en) Benzimidazolone derivatives
US4675334A (en) Tetrazolyl compounds and their use as anti allergic agents
SU858570A3 (ru) Способ получени производных 3-/тетразол-5-ил/-1-азаксантона или их солей
JPS6399057A (ja) グリシン誘導体
JPH0559117B2 (en, 2012)
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
JPH0573754B2 (en, 2012)
JP2765001B2 (ja) プロテアーゼ阻害剤